it depends on the company, recently BOT a similar cannabis company released a trial results. The results were good but the market did not understand the scientific terminology in the announcement so many sold
Howere, they had only two trails going on, IHL needs only one of the 6 programs to progress. There are peer reviewed published research supporting that all 6 programs actually work. All 6 programs showed good results in Vivo. IHL was told that all 6 program will qualify for FDA fast approval.
also BOT was trying for a condition with an existing medication in the market while all 6 programs have no existing approved medicine. That’s the same that GW pharma did which got acquire for 7 times the share price for only one approved drug.
- Forums
- ASX - By Stock
- General discussion
it depends on the company, recently BOT a similar cannabis...
-
-
- There are more pages in this discussion • 11,162 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online